IntroductionRhodococcus equi is a gram-positive, nonmotile, obligate aerobic, intracellular microorganism. This organism is a facultative pathogen that causes pneumonia in foals. This pathogen also causes ulcerative enterocolitis, osteomyelitis, and septic arthritis in rare cases. R. equi is present in the soil and in horse feces. Foals are thought to become infected when they ingest or breathe in soil, dust, or fecal particles harboring the bacteria within the first few days of life (1,2). Inhalation of aerosolized virulent R. equi from the environment and intracellular replication within alveolar macrophages are essential components of the pathogenesis of R. equi pneumonia in foals (3). Virulence of R. equi is associated with the presence of plasmids of 80-90 kb that encode the 15-17 kDa lipoprotein virulence-associated protein A (VapA) (4). Clinical symptoms typically appear in less than 6 months. However, protection of the newborn foal is most important during the first week (5). In addition, R. equi may cause infections in the lungs of horses (6). R. equi pneumonia significantly impacts the equine industry by causing financial losses because foals that recover from the disease are less likely to race as adults (7). The strategies used to protect against R. equi infection remain unsuccessful in foals. Although the use of a combination of antibiotics, such as rifamycin and erythromycin, is preferred in the treatment of this infection, the therapeutic effects are inconsistent due to bacteria that grow within cells and create granulomatous abscesses. In addition, the long-term use of antibiotics has potential risks, such as the development of resistance to antibiotics. The immunization of mares has been suggested by several researchers to prevent R. equi infection in foals (8-10).In this study, the efficacy of R. equi vaccines was determined in mice for the protection of Arabian foals against R. equi infection. To achieve this aim, 4 inactive vaccine candidates and a live vaccine were prepared using the VapA + K2002 strain of R. equi.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.